Literature DB >> 25221630

Synthesis and characterization of transferrin-targeted chemotherapeutic delivery systems prepared via RAFT copolymerization of high molecular weight PEG macromonomers.

Debashish Roy1, Geoffrey Y Berguig1, Bilal Ghosn1, Daniel Lane1, Scott Braswell1, Patrick S Stayton1, Anthony J Convertine1.   

Abstract

Reversible addition-fragmentation chain transfer (RAFT) polymerization was employed to prepare a nanoparticulate drug delivery system for chemotherapeutics. The nanoparticles contain a PEG "stealth" corona as well as reactive anhydride functionality designed for conjugating targeting proteins. The multifunctional carrier functionality was achieved by controlling the copolymerization of the hydrophobic monomer lauryl methacrylate (LMA), with a reactive anhydride functional methacrylate (TMA), and a large polyethyleneglycol methacrylate monomer (Mn~950 Da) (O950). RAFT polymerization kinetics of O950 were evaluated as a function of target degrees of polymerization (DP), initial chain transfer agent to initiator ratio ([CTA]o/[I]o), and solvent concentration. Excellent control over the polymerization was observed for target DPs of 25 and 50 at [CTA]o/[I]o ratio of 10 as evidenced by narrow and symmetric molecular weight distributions and the ability to prepare block copolymers. The TMA-functional copolymers were conjugated to the tumor targeting protein transferrin (Tf). The targeted copolymer was shown to encapsulate docetaxel at concentrations comparable to the commercial single vial formulation of docetaxel (Taxotere). In vitro cytotoxicity studies conducted in HeLa cells show that the Tf targeting enhances the cancer killing properties relative to the polymer encapsulated docetaxel formulation.

Entities:  

Year:  2014        PMID: 25221630      PMCID: PMC4159953          DOI: 10.1039/C3PY01404E

Source DB:  PubMed          Journal:  Polym Chem        ISSN: 1759-9954            Impact factor:   5.582


  16 in total

1.  The complex role of multivalency in nanoparticles targeting the transferrin receptor for cancer therapies.

Authors:  Jin Wang; Shaomin Tian; Robby A Petros; Mary E Napier; Joseph M Desimone
Journal:  J Am Chem Soc       Date:  2010-08-18       Impact factor: 15.419

Review 2.  Polymeric micelles in anticancer therapy: targeting, imaging and triggered release.

Authors:  Chris Oerlemans; Wouter Bult; Mariska Bos; Gert Storm; J Frank W Nijsen; Wim E Hennink
Journal:  Pharm Res       Date:  2010-08-20       Impact factor: 4.200

3.  Synthesis and reactivities of 3-indocyanine-green-acyl-1,3-thiazolidine-2-thione (ICG-ATT) as a new near-infrared fluorescent-labeling reagent.

Authors:  T Hirata; H Kogiso; K Morimoto; S Miyamoto; H Taue; S Sano; N Muguruma; S Ito; Y Nagao
Journal:  Bioorg Med Chem       Date:  1998-11       Impact factor: 3.641

4.  Radioactive labeling of defined HPMA-based polymeric structures using [18F]FETos for in vivo imaging by positron emission tomography.

Authors:  Matthias M Herth; Matthias Barz; Dorothea Moderegger; Mareli Allmeroth; Markus Jahn; Oliver Thews; Rudolf Zentel; Frank Rösch
Journal:  Biomacromolecules       Date:  2009-05-08       Impact factor: 6.988

5.  One-pot conversion of RAFT-generated multifunctional block copolymers of HPMA to doxorubicin conjugated acid- and reductant-sensitive crosslinked micelles.

Authors:  Zhongfan Jia; Lingjiun Wong; Thomas P Davis; Volga Bulmus
Journal:  Biomacromolecules       Date:  2008-10-10       Impact factor: 6.988

6.  Targeting vault nanoparticles to specific cell surface receptors.

Authors:  Valerie A Kickhoefer; Muri Han; Sujna Raval-Fernandes; Michael J Poderycki; Raymond J Moniz; Dana Vaccari; Mariena Silvestry; Phoebe L Stewart; Kathleen A Kelly; Leonard H Rome
Journal:  ACS Nano       Date:  2009-01-27       Impact factor: 15.881

7.  Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer.

Authors:  M E R O'Brien; N Wigler; M Inbar; R Rosso; E Grischke; A Santoro; R Catane; D G Kieback; P Tomczak; S P Ackland; F Orlandi; L Mellars; L Alland; C Tendler
Journal:  Ann Oncol       Date:  2004-03       Impact factor: 32.976

8.  Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis.

Authors:  Eric A Murphy; Bharat K Majeti; Leo A Barnes; Milan Makale; Sara M Weis; Kimberly Lutu-Fuga; Wolfgang Wrasidlo; David A Cheresh
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-07       Impact factor: 11.205

9.  Pegylated liposomal doxorubicin plus docetaxel significantly improves time to progression without additive cardiotoxicity compared with docetaxel monotherapy in patients with advanced breast cancer previously treated with neoadjuvant-adjuvant anthracycline therapy: results from a randomized phase III study.

Authors:  Joseph A Sparano; Anatoly N Makhson; Vladimir F Semiglazov; Sergei A Tjulandin; Olga I Balashova; Igor N Bondarenko; Natalia V Bogdanova; George M Manikhas; Gennadiy P Oliynychenko; Valery A Chatikhine; Sen H Zhuang; Liang Xiu; Zhilong Yuan; Wayne R Rackoff
Journal:  J Clin Oncol       Date:  2009-08-17       Impact factor: 44.544

10.  Polymeric nanoparticles with encapsulated superparamagnetic iron oxide and conjugated cisplatin for potential bladder cancer therapy.

Authors:  Chao Huang; Koon Gee Neoh; Liqun Xu; En Tang Kang; Edmund Chiong
Journal:  Biomacromolecules       Date:  2012-07-23       Impact factor: 6.988

View more
  6 in total

1.  Intracellular delivery system for antibody-Peptide drug conjugates.

Authors:  Geoffrey Y Berguig; Anthony J Convertine; Shani Frayo; Hanna B Kern; Erik Procko; Debashish Roy; Selvi Srinivasan; Daciana H Margineantu; Garrett Booth; Maria Corinna Palanca-Wessels; David Baker; David Hockenbery; Oliver W Press; Patrick S Stayton
Journal:  Mol Ther       Date:  2015-02-11       Impact factor: 11.454

2.  Well-defined single polymer nanoparticles for the antibody-targeted delivery of chemotherapeutic agents.

Authors:  D D Lane; D Y Chiu; F Y Su; S Srinivasan; H B Kern; O W Press; P S Stayton; A J Convertine
Journal:  Polym Chem       Date:  2015-02-28       Impact factor: 5.582

3.  Dynamic intracellular delivery of antibiotics via pH-responsive polymersomes.

Authors:  D D Lane; F Y Su; D Y Chiu; S Srinivasan; J T Wilson; D M Ratner; P S Stayton; A J Convertine
Journal:  Polym Chem       Date:  2015-02-28       Impact factor: 5.582

4.  Zwitterionic Nanocarrier Surface Chemistry Improves siRNA Tumor Delivery and Silencing Activity Relative to Polyethylene Glycol.

Authors:  Meredith A Jackson; Thomas A Werfel; Elizabeth J Curvino; Fang Yu; Taylor E Kavanaugh; Samantha M Sarett; Mary D Dockery; Kameron V Kilchrist; Ayisha N Jackson; Todd D Giorgio; Craig L Duvall
Journal:  ACS Nano       Date:  2017-06-07       Impact factor: 15.881

5.  Imaging the delivery of drug-loaded, iron-stabilized micelles.

Authors:  Suzanne J Bakewell; Adam Carie; Tara L Costich; Jyothi Sethuraman; J Edward Semple; Bradford Sullivan; Gary V Martinez; William Dominguez-Viqueira; Kevin N Sill
Journal:  Nanomedicine       Date:  2017-01-20       Impact factor: 5.307

6.  Theranostic Copolymers Neutralize Reactive Oxygen Species and Lipid Peroxidation Products for the Combined Treatment of Traumatic Brain Injury.

Authors:  Aaron Priester; Richard Waters; Ashleigh Abbott; Krista Hilmas; Klaus Woelk; Hunter A Miller; Aria W Tarudji; Connor C Gee; Brandon McDonald; Forrest M Kievit; Anthony J Convertine
Journal:  Biomacromolecules       Date:  2022-03-22       Impact factor: 6.978

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.